Thursday, August 03, 2017 10:07:45 AM
Under the terms of the contract, Absolu will immediately begin work on developing the branding of the new MSN-2 medical device; including the brand name, visual identity (logo, packaging, artwork), and marketing language around the new product. In Phase Two of the contract, Absolu will develop a secure transactional website, which will allow ETST to sell the device via the web to customers anywhere in the world. The additional security concern will help ensure customers' identities and personal information are protected. In Phase Three, the agency will deliver a Communications and Marketing Action Plan for the rollout of the new device. They will also manage the launch of the MSN-2, and the accompanying publicity.
"We are very proud to be working with Absolu on the pre-launch and launch of the MSN-2, and we hope to continue our relationship as we roll out our new nutrition and nutraceutical products in the coming year," said Chief Executive Officer and Chief Scientific Officer Michel Aubé, PhD.
The MSN-2 medical device is a new product, which will allow women to manage their own testing for Sexually Transmitted Diseases. Using MSN-2, women can collect their own cell sample in the privacy of their home and send it anonymously to a dedicated laboratory for testing. The MSN-2 is slated to launch during Q1 2018, and has been a key component of the company-wide women's health initiatives.
ETST's President, Director, and COO, Nickolas S. Tabraue concluded, "We expect to sign an agreement within three weeks for an exclusive distribution of a new medical devices manufacture by our future partner in two countries. This is an important step, as the release of our own MSN-2 medical device will be in the same timeline as this second medical device. We will have two medical devices ready to market overseas first, and in North America shortly after. This is an important step, as releasing our medical device in the North American markets will likely be delayed by several months, due to the complex nature of the regulatory environment in the US and Canada. We plan on updating our shareholders as further progress and development occurs."
http://www.nasdaq.com/press-release/earth-science-tech-inc-signs-contract-with-absolu-to-advance-phase-2-rollout-on-msn-2-medical-device-20170803-01033
Helping new traders avoid my old mistakes #chedsblog
Recent ETST News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/16/2024 05:24:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/05/2024 10:44:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/05/2024 10:04:15 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 07/29/2024 08:05:49 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 07/25/2024 12:55:56 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/18/2024 11:04:05 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/16/2024 06:30:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/12/2024 12:06:53 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/23/2024 10:10:23 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/22/2024 12:28:36 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/16/2024 03:10:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/13/2024 06:23:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 08:21:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2024 12:52:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/29/2024 11:20:11 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 02/27/2024 01:30:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 11:05:20 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/29/2024 02:05:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/26/2024 05:20:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2023 12:59:37 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/24/2023 11:01:45 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM